< Go back *Tips for better searches PsychiatryOnline topic: monoamine oxidase inhibitors   Book Results (87)   Journal Results (589)   Guideline Results (19) Journal Results (589) Guideline Results (19) Book Results (87) > APA Practice Guidelines (19) Textbook of Psychiatry (23) Psychopharmacology Patient Handouts (1) Manual of Clinical Psychopharmacology (12) Gabbard's Treatments of Psychiatric Disorders (8) Textbook of Substance Abuse Treatment (1) Textbook of Geriatric Psychiatry (3) Textbook of Psychopharmacology (18) Dulcan's Textbook of Child and Adolescent Psychiatry (2) Limit book results by topic: monoamine oxidase inhibitors > – in acute stress disorder – adhd and – administration – in adolescent patients – adverse effects – attention deficit/hyperactivity disorder and – in bipolar disorder – in borderline personality disorder – borderline personality disorder and – cardiovascular effects – central nervous system effects – chemical structure – in child and adolescent psychiatry – classification – clinical use – dietary interactions – dietary restrictions and – discontinuation – dosage – dosing – drug augmentation for – drug interactions – drug interactions – drug-drug interactions – efficacy – food restrictions – food-drug interactions – formulations – geriatric depression and – geriatric dosage – historical background – historical development – hypertensive crisis and – indications – intermittent explosive disorder and – irreversible – lactaction and – lactation and – in major depressive disorder – mechanism of action – in obsessive-compulsive disorder – ocd and – overdose – in panic disorder – pediatric anxiety and – in pediatric patients – pharmacokinetics – pharmacological effects – pharmacology – in post-traumatic stress disorder – post-traumatic stress disorder and – in pregnancy – pregnancy and – ptsd and – reversible – risk factors – serotonin syndrome and – sexual dysfunction and – sexual dysfunction and – side effects – social phobia and – strength – tobacco dependence and – toxicity – toxicology – tyramine and – weight gain and 1-20 of 87 Book Results Next Results > 1.  (4) Monoamine oxidase inhibitors APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Acute Phase Somatic Treatments > 1. Antidepressant medications > c) Side effects 2.  (4) Monoamine oxidase inhibitors APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Acute Phase Somatic Treatments > 1. Antidepressant medications > b) Efficacy 3.  1. Psychopharmacology APA Practice Guidelines > TREATING PATIENTS WITH ACUTE STRESS DISORDER AND POSTTRAUMATIC STRESS DISORDER: A Quick Reference Guide > D. Specific Treatment Strategies 4.  3. MAOI antidepressants APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > B. Somatic Treatments of Acute Depressive Episodes 5.  3. MAOI antidepressants APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments 6.  a. Monoamine oxidase inhibitors APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part B. Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > C. Pharmacological Interventions > 5. Other antidepressants 7.  a. Monoamine Oxidase Inhibitors APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder > Part B. Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Medications > 4. Other Antidepressants 8.  Adverse effects are a major concern with MAOIs, and these medications are generally reserved... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part A. Treatment Recommendations > II. Formulation and Implementation of a Treatment Plan > H. Specific Pharmacological Interventions > 5. Other antidepressants 9.  b) Tricyclic antidepressants and MAOIs APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder > Part A: Treatment Recommendations > II. Formulation and Implementation of a Treatment Plan > D. Specific Treatment Strategies > 1. Psychopharmacology 10.  b) Efficacy APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments > 3. MAOI antidepressants 11.  c) Side effects APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments > 3. MAOI antidepressants 12.  d) MAOIs APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > C. Pharmacotherapies > 1. Antidepressants 13.  d) Implementation issues APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments > 3. MAOI antidepressants 14.  d) Using a monoamine oxidase inhibitor APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Acute Phase Somatic Treatments > 2. Failure to respond to pharmacotherapy in the acute phase 15.  If one first-line treatment (e.g., CBT, an SSRI, an SNRI) has failed, adding or switching to... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part A. Treatment Recommendations > I. Executive Summary > C. Formulation and Implementation of a Treatment Plan > 5. Approaches to try when a first-line treatment is unsuccessful 16.  If the above treatment options, which have the highest levels of empirical support, have been... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part A. Treatment Recommendations > II. Formulation and Implementation of a Treatment Plan > F. Approaches to Try When a First-Line Treatment Is Unsuccessful 17.  Monoamine oxidase inhibitors are widely regarded as effective for panic disorder. However,... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part A. Treatment Recommendations > II. Formulation and Implementation of a Treatment Plan > H. Specific Pharmacological Interventions > 5. Other antidepressants 18.  Selective serotonin reuptake inhibitors, SNRIs, TCAs, and benzodiazepines have demonstrated... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part A. Treatment Recommendations > I. Executive Summary > C. Formulation and Implementation of a Treatment Plan > 7. Specific pharmacological interventions 19.  The efficacy of MAOIs for affective dysregulation symptoms in patients with borderline... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part A: Treatment Recommendations for Patients With Borderline Personality Disorder > II. Formulation and Implementation of a Treatment Plan > D. Specific Treatment Strategies for the Clinical Features of Borderline Personality Disorder > 2. Pharmacotherapy and other somatic treatments > a) Treatment of affective dysregulation symptoms 20.  TABLE 26–3. Key side effects of major antidepressant drugs Textbook of Psychiatry > Chapter 26. Psychopharmacology > Antidepressant Medications > Clinical Use 1-20 of 87 Book Results Next Results > Do a full-text search for "monoamine oxidase inhibitors"